SEC Tracker
Get the app
SCNX · XBRL financial data

Scienture Holdings financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (SCNX's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024†Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue——————100*——56344
Revenue from contracts with customers2,0582,352*—196553*100*590(169)*56344
Cost of revenue353year only—196150*100*—year only28
Cost of goods and services sold353year only—196150*100*1575*28
Gross profit1,705——(1)43*10*575(244)*54336
Research and development————1,254983*575844169369*7941,167
General and administrative6141,521*4,7014151691,393*1,3562,9282,1651,477*1,075369
Total operating expenses2,5503,944*5,4961,4953,5024,217*3,5725,1584,93629,257*3,5633,036
Operating income (loss)(845)(6,193)*(5,496)(1,496)(3,498)(4,215)*(3,571)(5,158)(4,361)(29,500)*(3,509)(2,700)
Interest expense252703*9952171,015*6716531,803955*37270
Income tax expense (benefit)—————year only———year only——
Net income (loss)(3,525)(11,716)*21,246(1,834)(3,184)(7,163)*(3,064)(6,721)(3,607)(28,120)*(3,402)(2,822)
Earnings per share, basic USD per share(4.57)—20.49(1.30)(1.34)—(0.33)(0.48)(0.19)—(0.08)(0.07)
Earnings per share, diluted USD per share(1.49)—16.77(1.30)(1.34)—(0.33)(0.48)(0.19)—(0.08)(0.07)
Weighted average shares, basic thousands of shares771—1,0371,4062,374—9,42614,14118,95818,723*40,63139,616
Weighted average shares, diluted thousands of shares2,363—1,2671,4062,374—9,42614,14118,95818,723*40,63139,616
  • † Share count changed about 6x in the period ending 2024-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (SCNX's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024†Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents341523,4997,7205793082,050153566,6623,5438,188
Accounts receivable85082271310114—590731723385
Inventory3,0271568———235213211203
Prepaid and other current assets—51——775———————
Total current assets5,5482,75314,02712,1447,2566,3057,8258571,4217,9164,7749,202
Property and equipment, net288277771818171716161515
Right-of-use asset1,188530183176215201187302323102
Goodwill5,129———7,84921,37321,37321,37321,373———
Total assets21,65412,53316,73914,84994,260104,854106,359104,295104,83084,17880,66287,734
Accounts payable1,3292,0829537262,9042,8993,1853,1363,6731,4431,405917
Accrued liabilities3864014935001,0431,3141,4111,800985657704504
Total current liabilities9,09211,5562,9512,9025,4137,9077,4627,6887,3512,7352,8043,026
Total deposits—————————1,182—2,208
Lease liability, non-current9774091691611731561393————
Total liabilities10,09411,9913,1203,0639,12825,78225,19626,43422,16114,05813,84123,632
Accumulated deficit(21,530)(33,246)(24,671)(26,505)(31,876)(39,039)(42,103)(48,824)(52,431)(80,551)(83,954)(86,776)
Total stockholders' equity11,56054213,61911,78585,13279,07281,16377,86082,67070,12066,82064,102
Total liabilities and equity21,65412,53316,73914,84994,260104,854106,359104,295104,83084,17880,66287,734
Common shares outstanding (cover page) thousands of shares1,2051,4061,4061,4598,57712,51513,11616,13140,63140,63140,63141,064
  • † Share count changed about 6x in the period ending 2024-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (SCNX's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024†Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(3,525)(11,716)*21,246(1,834)(3,184)(7,163)*(3,064)(6,721)(3,607)(28,120)*(3,402)(2,822)
Stock-based compensation4*4*24——0*0162*1,658*248*102103*
Net cash from operating activities(603)*(1,019)*(10,190)4,222*(5,388)*(2,909)*(2,956)(2,034)*(3,214)*(5,175)*(2,919)(3,132)*
Purchases of property and equipment—————0*——————
Net cash from investing activities(207)*(350)*27,433(1)*121*0*——————
Proceeds from issuing common stock—————year only4,5980*6,871*14,824*——
Proceeds from issuing equity—————year only——————
Dividends paid——12,6710*2,188*0*——————
Net cash from financing activities115*1,335*(13,896)0*(1,874)*2,790*4,6980*3,554*11,482*(200)10,790*
Net change in cash(695)*118*3,3474,221*(7,141)*(119)*1,742(2,034)*340*6,306*(3,119)7,658*
  • † Share count changed about 6x in the period ending 2024-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Scienture Holdings8,188344(3,132)*41.1M2.6 quarters 10-QJun 30, 2026
Kiora Pharmaceuticals7,077not reported(1,892)*4.4M8.9 quarters 10-QJun 30, 2026
Brainstorm Cell Therapeutics22not reported(895)11.0M0.0 quarters 10-QJun 30, 2026
LeonaBio32,323not reported(16,958)*9.4M3.0 quarters 10-QJun 30, 2026
Mannatech6,03426,650(792)*1.9M7.6 quarters 10-QJun 30, 2026
Traws Pharma5,016not reported(7,504)*15.4M0.7 quarters 10-QJun 30, 2026
BioCardia4,117not reported(1,735)*15.1M2.4 quarters 10-QJun 30, 2026
Alaunos Therapeutics1240(300)*2.5M0.4 quarters 10-QJun 30, 2026
Raphael Pharmaceutical1not reported0*20.2M— 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.